This story was originally published on Feb. 8.

Rheonix said today that it has received a $500,000 Small Business Innovation Research grant from the National Science Foundation to continue developing its Chemistry and Reagent Device, or CARD, system to detect certain types of water contamination.

The Phase II SBIR is based upon the successful completion of a Phase I and IB project in which Rheonix developed its PCR-based testing system to rapidly detect fecal indicator bacteria in recreational water.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.